What are the guidelines for hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus?
According to the American College of Physicians, hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus are outlined in Clinical Guidelines Committee of the American College of Physicians' guidance statement update from the American College of Physicians (Qaseem et al., 2018). The guidance statement recommends that hemoglobin A1c targets should be set at less than 7.0% with the goal of less than 6.5%. Additionally, the American Geriatrics Society Expert Panel on Care of Older Adults With Diabetes Mellitus (2013) recommends that hemoglobin A1c targets for older adults with type 2 diabetes should be set at less than 8.0%, with the goal of less than 7.0%.  